| |
| |
|
| Insider
Information: |
Mehra Anand |
| Relationship: |
Director |
| City: |
Menlo Park |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
11 |
|
| Direct
Shares |
11,769,795 |
|
|
Indirect Shares
|
6,925,513 |
|
|
| Direct
Value |
$208,452,725 |
|
|
|
Indirect Value
|
$127,416,731 |
|
|
| Total
Shares |
18,695,308 |
|
|
| Total
Value |
$335,869,456 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Aerie Pharmaceuticals Inc |
AERI |
Director |
2015-04-10 |
1,700 |
2015-04-15 |
469,591 |
Premium* |
|
|
Alimera Sciences Inc |
ALIM |
10% Owner |
2014-09-12 |
40,020 |
2014-09-12 |
506,270 |
Premium* |
|
|
Ocugen Ord Shs |
OCGN |
10% Owner |
2014-12-08 |
0 |
2014-12-08 |
2,077,040 |
Premium* |
|
|
Spark Therapeutics, Inc. |
ONCE |
Director |
2019-12-17 |
0 |
2019-12-17 |
0 |
Premium* |
|
|
aTyr Pharma Inc |
LIFE |
10% Owner |
2015-05-12 |
1,866,126 |
2015-05-12 |
0 |
Premium* |
|
|
Synlogic Inc |
SYBX |
10% Owner |
2015-10-06 |
2,974,811 |
2015-10-05 |
0 |
Premium* |
|
|
Aclaris Therapeutics, Inc. |
ACRS |
Director |
2023-06-02 |
38,704 |
2018-10-22 |
1,911,573 |
Premium* |
|
|
Iterum Therapeutics Plc |
ITRM |
10% Owner |
2018-05-30 |
1,726,514 |
2018-05-30 |
0 |
Premium* |
|
|
Principia Biopharma Inc |
PRNB |
10% Owner |
2018-09-18 |
2,038,208 |
2018-09-18 |
0 |
Premium* |
|
|
Galera Therapeutics, Inc. |
GRTX |
10% Owner |
2019-11-12 |
3,083,712 |
2019-11-12 |
0 |
Premium* |
|
|
Merus Nv |
MRUS |
Director |
|
0 |
2020-01-01 |
1,961,039 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
78 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SYBX |
Synlogic Inc |
10% Owner |
– – • |
2015-10-06 |
4 |
B |
$7.00 |
$5,999,994 |
D/D |
857,142 |
2,974,811 |
2.45 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Director |
– • – |
2018-10-22 |
4 |
B |
$10.75 |
$4,000,000 |
I/I |
372,093 |
1,911,573 |
2.1 |
- |
|
| OCGN |
Ocugen Ord Shs |
10% Owner |
– – • |
2014-12-08 |
4 |
B |
$11.00 |
$5,502,178 |
I/I |
500,198 |
2,085,848 |
1.5 |
- |
|
| OCGN |
Ocugen Ord Shs |
10% Owner |
– – • |
2014-12-08 |
4 |
S |
$11.00 |
$11,022 |
I/I |
(1,002) |
1,585,650 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Director |
– • • |
2015-10-13 |
4 |
B |
$11.00 |
$4,499,990 |
I/I |
409,090 |
2,289,480 |
2.25 |
- |
|
| GRTX |
Galera Therapeutics, Inc. |
10% Owner |
– – • |
2019-11-12 |
4 |
B |
$12.00 |
$9,000,000 |
D/D |
750,000 |
3,083,712 |
2.45 |
- |
|
| ITRM |
Iterum Therapeutics Plc |
10% Owner |
– – • |
2018-05-30 |
4 |
B |
$13.00 |
$6,500,000 |
D/D |
500,000 |
1,726,514 |
2.45 |
- |
|
| LIFE |
aTyr Pharma Inc |
10% Owner |
– – • |
2015-05-12 |
4 |
B |
$14.00 |
$4,480,000 |
D/D |
320,000 |
1,866,126 |
2.45 |
- |
|
| PRNB |
Principia Biopharma Inc |
10% Owner |
– – • |
2018-09-18 |
4 |
B |
$17.00 |
$4,590,000 |
D/D |
270,000 |
2,038,208 |
2.45 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Director |
– • – |
2021-02-02 |
4 |
OE |
$18.32 |
$268,298 |
D/D |
14,632 |
30,841 |
0 |
- |
|
| ONCE |
Spark Therapeutics, Inc. |
Director |
– • – |
2015-02-04 |
4 |
B |
$23.00 |
$5,175,000 |
I/I |
225,000 |
2,118,576 |
2.1 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
10% Owner |
– – • |
2014-07-09 |
4 |
S |
$24.00 |
$24,001,300 |
I/I |
(1,000,000) |
1,566,657 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
10% Owner |
– – • |
2014-07-10 |
4 |
S |
$25.81 |
$207,030 |
I/I |
(8,022) |
0 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Director |
– • – |
2014-11-25 |
4 |
S |
$26.00 |
$20,800,000 |
I/I |
(800,000) |
766,657 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Director |
– • – |
2017-01-10 |
4 |
S |
$28.25 |
$21,188,325 |
I/I |
(750,000) |
1,539,480 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Director |
– • – |
2015-04-15 |
4 |
S |
$33.45 |
$9,843,886 |
I/I |
(294,298) |
469,591 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Director |
– • – |
2015-04-14 |
4 |
S |
$34.08 |
$4,453,880 |
I/I |
(130,702) |
763,889 |
0 |
- |
|
| ONCE |
Spark Therapeutics, Inc. |
Director |
– • – |
2015-10-08 |
4 |
S |
$44.38 |
$12,473,634 |
I/I |
(277,632) |
1,589,032 |
0 |
- |
|
| ONCE |
Spark Therapeutics, Inc. |
Director |
– • – |
2015-10-07 |
4 |
S |
$45.56 |
$11,600,801 |
I/I |
(251,912) |
1,866,664 |
0 |
- |
|
| ONCE |
Spark Therapeutics, Inc. |
Director |
– • – |
2016-12-09 |
4 |
S |
$53.07 |
$5,571,532 |
I/I |
(100,251) |
1,276,923 |
0 |
- |
|
| ONCE |
Spark Therapeutics, Inc. |
Director |
– • – |
2016-12-15 |
4 |
S |
$53.07 |
$3,711,079 |
I/I |
(69,928) |
1,184,714 |
0 |
- |
|
| ONCE |
Spark Therapeutics, Inc. |
Director |
– • – |
2016-12-16 |
4 |
S |
$53.26 |
$14,980,813 |
I/I |
(279,728) |
904,986 |
0 |
- |
|
| ONCE |
Spark Therapeutics, Inc. |
Director |
– • – |
2016-12-13 |
4 |
S |
$53.32 |
$1,188,023 |
I/I |
(22,281) |
1,254,642 |
0 |
- |
|
| ONCE |
Spark Therapeutics, Inc. |
Director |
– • – |
2015-11-12 |
4 |
S |
$60.00 |
$64,440 |
I/I |
(1,074) |
1,458,427 |
0 |
- |
|
| ONCE |
Spark Therapeutics, Inc. |
Director |
– • – |
2016-05-31 |
4 |
AS |
$60.00 |
$30,000 |
I/I |
(500) |
1,434,966 |
0 |
- |
|
78 Records found
|
|
Page 2 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
